Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways

It has been established that monotherapy yields limited efficacy in treating hepatocellular carcinoma (HCC), especially advanced HCC. Increasing evidence from preclinical studies and clinical trials indicates that combining multiple drugs can potentially refine treatment efficacy. Accordingly, it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xijing, Yu, Haoyuan, Liang, Jinliang, Hu, Zhongying, Li, Xuejiao, Liu, Huanyi, Yao, Jia, Sui, Xin, Zheng, Jun, Li, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654680/
https://www.ncbi.nlm.nih.gov/pubmed/37973900
http://dx.doi.org/10.1038/s41420-023-01664-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654680/
https://www.ncbi.nlm.nih.gov/pubmed/37973900
http://dx.doi.org/10.1038/s41420-023-01664-y

Ejemplares similares